Error: Could not add to watchlist. X
+ Watchlist

Furiex Pharmaceuticals LLC

FURX:US
Acquired
FURX:US was acquired by AGN:US
USD
Volume
0
Before it's here, it's on the Bloomberg Terminal.
Learn More
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-5.05
Market Cap (USD)
-
Shares Outstanding (m)
10.816
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Furiex Pharmaceuticals, Inc. operates as a drug development company. The Company partners with pharmaceutical and biotechnology companies and provides diversified product portfolio and pipeline with multiple therapeutic candidates including late-stage assets and products in the markets. Furiex serves customers in the State of North Carolina.
Address
3900 Paramount Parkway
Suite 150
Morrisville, NC 27560
United States
Phone
-
Show More